Brief: Caladrius Biosciences And Cend Therapeutics Announce Publication Of Pancreatic Cancer Trial Data In The Lancet Gastroenterology And Hepatology
06/07/2022 13:48
July 6 (Reuters) - Caladrius Biosciences Inc CLBS.O :
* CALADRIUS BIOSCIENCES AND CEND THERAPEUTICS ANNOUNCE
PUBLICATION
OF PANCREATIC CANCER TRIAL DATA IN THE LANCET GASTROENTEROLOGY
AND HEPATOLOGY
Source text for Eikon: ID:nGNX2S2NSt
Further company coverage: CLBS.O
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal